Doctors
This page lists 41 references in the Main Healthy Skepticism Library relevant to Doctors.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL5954
Irvine D.
Book: Measuring Medical Professionalism; Understanding Doctors' Performance (Review)
BMJ 2006 Jul 1;333(7557):49
http://bmj.bmjjournals.com/cgi/content/short/333/7557/49?etoc
HSL6554
Amaral OB.
Defining disease in the information age.
PLoS Med 2006 Jul 01;3(7):e317
Link to source with long URL
HSL6735
Morgan MA, Dana J, Loewenstein G, Zinberg S, .
Interactions of doctors with the pharmaceutical industry
J Med Ethics 2006;32:559-563
http://jme.bmjjournals.com/cgi/content/full/32/10/559
HSL5862
Chase J.
Physicians on pharma
Med Mark Media 2005 Dec 1;40:62-63
HSL1872
Dabade G.
Remembering a health campaigner
Deccan Herald 2005 May 23
HSL5468
Rataboli PV, Garg A.
Confusing brand names: nightmare of medical profession.
J Postgrad Med 2005 Jan-Mar;51(1):13-6
Link to source with long URL
HSL5282
Castresana L, Mejia R, Aznar M.
[The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Medicina (B Aires) 2005;65(3):247-51
HSL2215
Aasland OG, Forde R.
[Physicians and drug industry: attitudes and practice].
Tidsskr Nor Laegeforen 2004 10 21;124(20):2603-6
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1083681
HSL8521
Jackimiec JM.
Communicating utilization and critical issues to health providers
ASHP Annual Meeting 2001 Jun;58
HSL5442
Malpani A.
Doctors should be allowed to advertise.
Issues Med Ethics 2001 Jan-Mar;9(1):16-7
HSL2979
Canadian Medical Association
CMA Policy: Physicians and the pharmaceutical industry (Update 2001)
2001
Link to source with long URL
HSL8517
Kizer JR, Kimmel SE.
Calcium channel blocker controversy: historical perspective and important lessons for future pharmacotherapies-International Society of Pharmacoepidemiology hot topic
Pharmacoepidemiology and Drug Safety 2000;9(1):25-36
HSL8518
Nolan A.
Pharmaceutical advertising in clinical software
Australian Prescriber 2000;23(3):52-53, 67
HSL756
Strang D, Gagnon M, Molloy W, Bedard M, Darzins P, Etchells E, Davidson W.
National survey on the attitudes of Canadian physicians towards drug-detailing by pharmaceutical representatives.
Ann R Coll Physicians Surg Can 1996 Dec;29(8):474-8
HSL783
Joseph P.
Consumer product information affects us all: iv. medical practitioner view
Australian Prescriber 1996;19:33-34
HSL829
Petroshius SM, Titus PA, Hatch KJ.
Physician attitudes toward pharmaceutical advertising
J Advert Res 1995;35(6):41-51
HSL6283
Physicians and the pharmaceutical industry (update 1994)
Canadian Medical Association Journal 1994;150:256A-256C
HSL2071
Miller LG, Blum A.
Physician awareness of prescription drug costs: a missing element of drug advertising and promotion.
J Fam Pract 1993 Jan;36(1):33-6
HSL5138
Spiro HM.
Speaking out: A physician looks at direct-to-consumer advertising
Medical Marketing & Media 1992 Nov 1;27(11):24, 26, 28
HSL4889
Paterson AH.
Physicians and pharmaceutical companies
Canadian Medical Association Journal 1992;146:328
HSL4111
Postmarketing surveillance - how should doctors get involved?
Drug and Therapeutics Bulletin 1988 Nov 14;26(3):89-91
HSL4107
Rosenthal E.
Madison Avenue medicine
Discover 1988 Oct;9(10):34-36
HSL3856
Fakes RW.
Doctors and the drug industry [2nd of 4 letters]
British Medical Journal 1986 Nov 1;293:1170-1171
HSL3857
Lenox-smith I, Clifford JM.
Doctors and the drug industry [4th of 4 letters]
British Medical Journal 1986 Nov 1;293:1171
HSL3858
O'Dowd TC, Whibley R.
Doctors and the drug industry [3rd of 4 letters]
British Medical Journal 1986 Nov 1;293:1171
HSL3859
Wilkie CE.
Doctors and the drug industry [1st of 4 letters]
British Medical Journal 1986 Nov 1;293:1170
HSL3674
Physicians, pharmacists, and consumers react to a direct-to-consumer campaign
Medical Marketing & Media 1984 Apr 01;19(4):24, 26
HSL3610
Howie JG.
Doctors and the pharmaceutical industry [1st of 2 letters]
Journal of the Royal College of General Practitioners 1983 Dec;33:825
HSL3611
Taylor GB.
Doctors and the pharmaceutical industry [2nd of 2 letters]
Journal of the Royal College of General Practitioners 1983 Dec;33:825
HSL3564
Kushner D.
Two-thirds of RPh's & MD's object to makers' promotion of Rx drugs to the public
American Druggist 1982 Oct;186(1):14, 16, 21-22
HSL3534
Bainbridge CV, D'Ambrosio GG, Petrick RJ, Weiss EM.
Pharmaceutical manufacturer's responses to drug information inquiries.
Am J Hosp Pharm 1982 Sep;39(9):1532-4
HSL3518
Oppenheim GL, Erickson SH, Ashworth C.
The family physician's knowledge of the cost of prescribed drugs.
J Fam Pract 1981 Jun;12(6):1027-30
HSL3499
Curry L, Putnam RW.
Continuing medical education in Maritime Canada: the methods physicians use, would prefer and find most effective.
Can Med Assoc J 1981 Mar 1;124(5):563-6
HSL3500
Goldbloom D.
Drug companies and medical education: a modest proposal
McGill Medical Journal 1981;46(2):24
HSL3434
Miller JA, Waller R.
Health care advertising: consumer vs. physician attitudes
Journal of Advertising 1979;8(4):20-29
HSL2505
Mapes R.
Aspects of British general practitioners' prescribing.
Med Care 1977 May;15(5):371-81
Nil
HSL3301
Eaton G, Parish P.
General practitioners' views of information about drugs.
J R Coll Gen Pract 1976;26
HSL3335
Halberstam M.
The other side of the coin: another physician views drug advertising
Journal of Drug Issues 1976;6(1):9-12
HSL3344
Watson M.
A physician views drug advertising
Journal of Drug Issues 1976;6(1)
HSL3272
Harelik JH, Johnston PM, Rivers NP, Ryan MR.
Pharmacist and physician evaluation of drug information sources.
Am J Hosp Pharm 1975 Jun;32(6):594-7
HSL3135
Canadian doctors more sceptical of drug promotion than U.S. counterparts—report
Canadian Medical Association Journal 1970;102:884, 886